These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19884766)

  • 21. Measuring the Uptake and Transactivation Function of HIV-1 Tat Protein in a Trans-cellular Cocultivation Setup.
    Ruiz AP; Prasad VR
    Methods Mol Biol; 2016; 1354():353-66. PubMed ID: 26714724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation.
    Zhang HS; Li HY; Zhou Y; Wu MR; Zhou HS
    Free Radic Biol Med; 2009 Aug; 47(3):261-8. PubMed ID: 19409485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteome analysis of the HIV-1 Gag interactome.
    Engeland CE; Brown NP; Börner K; Schümann M; Krause E; Kaderali L; Müller GA; Kräusslich HG
    Virology; 2014 Jul; 460-461():194-206. PubMed ID: 25010285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decoding the multifaceted HIV-1 virus-host interactome.
    Chan EY; Korth MJ; Katze MG
    J Biol; 2009 Oct; 8(9):84. PubMed ID: 19833003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation.
    Boven LA; Noorbakhsh F; Bouma G; van der Zee R; Vargas DL; Pardo C; McArthur JC; Nottet HS; Power C
    J Neurovirol; 2007 Apr; 13(2):173-84. PubMed ID: 17505986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1.
    Lin MH; Sivakumaran H; Jones A; Li D; Harper C; Wei T; Jin H; Rustanti L; Meunier FA; Spann K; Harrich D
    Retrovirology; 2014 Dec; 11():121. PubMed ID: 25496916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mutant tat protein inhibits HIV-1 reverse transcription by targeting the reverse transcription complex.
    Lin MH; Apolloni A; Cutillas V; Sivakumaran H; Martin S; Li D; Wei T; Wang R; Jin H; Spann K; Harrich D
    J Virol; 2015 May; 89(9):4827-36. PubMed ID: 25673710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Tat/P-TEFb Protein-Protein Interaction Determining Transcriptional Activation of HIV.
    Asamitsu K; Okamoto T
    Curr Pharm Des; 2017; 23(28):4091-4097. PubMed ID: 28699519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-Vitro Subtype-Specific Modulation of HIV-1 Trans-Activator of Transcription (Tat) on RNAi Silencing Suppressor Activity and Cell Death.
    Ronsard L; Yousif AS; Ramesh J; Sumi N; Gorman M; Ramachandran VG; Banerjea AC
    Viruses; 2019 Oct; 11(11):. PubMed ID: 31652847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Tat protein of human immunodeficiency virus type 1 (HIV-1) can promote placement of tRNA primer onto viral RNA and suppress later DNA polymerization in HIV-1 reverse transcription.
    Kameoka M; Morgan M; Binette M; Russell RS; Rong L; Guo X; Mouland A; Kleiman L; Liang C; Wainberg MA
    J Virol; 2002 Apr; 76(8):3637-45. PubMed ID: 11907203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of Tat in HIV-1 replication: an activator and/or a suppressor?
    Liang C; Wainberg MA
    AIDS Rev; 2002; 4(1):41-9. PubMed ID: 11998784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infection.
    Huigen MC; Kamp W; Nottet HS
    Eur J Clin Invest; 2004 Jan; 34(1):57-66. PubMed ID: 14984439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
    Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PKM2-mediated inhibition of autophagy facilitates Tat's inducing HIV-1 transactivation.
    Zhang HS; Zhang ZG; Zhou Z; Du GY; Li H; Yu XY; Huang YH
    Arch Biochem Biophys; 2017 Jul; 625-626():17-23. PubMed ID: 28583828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential Effects of Strategies to Improve the Transduction Efficiency of Lentiviral Vector that Conveys an Anti-HIV Protein, Nullbasic, in Human T Cells.
    Rustanti L; Jin H; Li D; Lor M; Sivakumaran H; Harrich D
    Virol Sin; 2018 Apr; 33(2):142-152. PubMed ID: 29541943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
    Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA
    BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosome-associated release, uptake, and neurotoxicity of HIV-1 Tat protein.
    Rahimian P; He JJ
    J Neurovirol; 2016 Dec; 22(6):774-788. PubMed ID: 27173397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signatures of HIV-1 subtype B and C Tat proteins and their effects in the neuropathogenesis of HIV-associated neurocognitive impairments.
    Williams ME; Zulu SS; Stein DJ; Joska JA; Naudé PJW
    Neurobiol Dis; 2020 Mar; 136():104701. PubMed ID: 31837421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immunodeficiency virus type 1 Tat induces B7-H1 expression via ERK/MAPK signaling pathway.
    Shi J; Qin X; Zhao L; Wang G; Liu C
    Cell Immunol; 2011; 271(2):280-5. PubMed ID: 21821233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5.
    Ping YH; Chu CY; Cao H; Jacque JM; Stevenson M; Rana TM
    Retrovirology; 2004 Dec; 1():46. PubMed ID: 15620346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.